Crossmark

Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial

Crossref DOI link: https://doi.org/10.1186/s12879-019-3920-8

Published Online: 2019-04-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

El Guerche-Séblain, Clotilde https://orcid.org/0000-0003-0196-4357
Moureau, Annick

Schiffler, Camille

Dupuy, Martin

Pepin, Stephanie

Samson, Sandrine I.

Vanhems, Philippe

Schellevis, François
License Information

Text and Data Mining valid from 2019-04-04
More Information

Article History

Received: 1 November 2018

Accepted: 19 March 2019

First Online: 4 April 2019

Ethics approval and consent to participate

: The study was approved by the independent ethics committee or institutional review board for each study site (full details provided in Additional File ) and was conducted in accordance with Good Clinical Practice and the Declaration of Helsinki. Written informed consent was provided by the parents or legal representatives of all children participating in this trial.

: Not applicable.

: C.E.S., A.M., C.S., M.D., S.P., and S.S. are employees of Sanofi Pasteur. F.S. and P.V. declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.